Clinical trials
Abdominal Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 4 |
| Not yet recruiting | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catholic University of the Sacred Heart | 2 |
| Huazhong University of Science and Technology | 2 |
| Asan Medical Center | 1 |
| Assiut University | 1 |
| Centre Hospitalier Universitaire de Tivoli | 1 |
| Duke University | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| National Taiwan University Hospital | 1 |
| Royal Surrey County Hospital NHS Foundation Trust | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abdominal Neoplasms | 14 |
| Mediastinal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Hernia, Abdominal | 1 |
| Intestinal Obstruction | 1 |
| Intraabdominal Infections | 1 |
| Lung Diseases | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Ovarian Diseases | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.